ArticleEndocrinology2025
ATF4 Deletion in Brown Adipocytes Attenuates Diet-Induced Insulin Resistance in Male Mice Independently of Weight Gain.
Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inhibition of adipocyte RUNX1/2 enhances adipose tissue thermogenesis through distinct mechanisms.Nature communications · 2026Article
- Coixol and Sinigrin fromPharmaceuticals (Basel, Switzerland) · 2025Article
- ATF4 Deletion in Brown Adipocytes Attenuates Diet-Induced Insulin Resistance in Male Mice Independently of Weight Gain.Endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Expression of the activating transcription factor 4 (ATF4) in thermogenic adipocytes is required to maintain core body temperature and systemic metabolic homeostasis in models of mitochondrial stress. We have recently shown that ATF4 is required for thermoregulation in response to cold stress in mice, establishing a role for ATF4 in regulating brown adipose tissue (BAT) function during physiological stress. In the present study, we investigated the role of ATF4 in thermogenic adipocytes in regulating glucose metabolism and energy homeostasis during diet-induced obesity (DIO). To this end, we generated mice with selective Atf4 deletion in BAT (ATF4 BKO). After 12 weeks of high-fat-feeding, ATF4 BKO mice had similar weight gain and total fat mass relative to wild-type mice. Accordingly, no changes in food intake, locomotor activity, or energy expenditure were detected between genotypes. Nonetheless, diet-induced glucose intolerance and insulin resistance were attenuated in ATF4 BKO mice, which correlated with reduced markers of inflammation and increased levels of glucose transporters in BAT. Taken together, our results indicate that Atf4 deficiency in BAT during DIO improves glucose homeostasis and insulin sensitivity in mice without affecting energy homeostasis. Mechanistically, our data suggest ATF4 deletion leads to repressed inflammation in BAT of obese mice, while likely increasing glucose uptake and utilization, thereby contributing to overall improvement in glucose homeostasis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.